Neurobiology of Brain Disorders (Second Edition), Biological Basis of Neurological and Psychiatric Disorders, 2022, Pages 313-336

This book chapter advances SDG #3 and #10 by reviewing several key topics that influence our understanding of pathogenic mechanisms and lead to the identification of novel therapeutic strategies. These include the diagnostic spectrum of MCI and AD, genetic risk alleles associated with late-onset AD, structures of gamma-secretase and tau, imaging and fluid biomarkers, the role of microglia and neuroinflammation, and novel animal models of AD.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 481-500

This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by examining how various pathogens cause a variety of central nervous system (CNS) dysfunctions and the mechanisms of these changes.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 147-164

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing the most recent scientific advances that have improved diagnostic abilities and showcasing experimental studies of gene therapy and conventional pharmacological treatments to lead to effective treatment of these hereditary disorders.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 233-251

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by highlighting amyotrophic lateral sclerosis (ALS), a neurodegenerative disease of the motor system characterized by focal and then generalized weakness leading to paralysis and death from respiratory failure.
Elsevier,

Neurobiology of Brain Disorders (Second Edition)
Biological Basis of Neurological and Psychiatric Disorders
2023, Pages 275-292

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on the clinical features, ethics, and neurobiology of HD and the exciting approaches being employed today to advance understanding of underlying mechanisms in an effort to develop therapies that would delay the onset and slow progression of this disease.
Elsevier,

Principles and Practice of Pediatric Infectious Diseases (Sixth Edition)

2023, Pages 1125-1133.e4

This content supports the SDG Goal 3: Good health and well-being by providing information on Hepatitis B and Hepatitis D Viruses.
Elsevier,

Principles and Practice of Pediatric Infectious Diseases (Sixth Edition)
2023, Pages 1237-1243.e3

This content supports the SDG Goal 3: Good health and well-being by discussing the pathogens, epidemiology, clniical manifestations, laboratory findings, treatment and prevention of Hepatitis A.
Elsevier,

Pandemic Risk, Response, and Resilience: COVID-19 Responses in Cities Around the World, 2022, Pages 207-217

This chapter advances Goals 16, 10, and 3 by assessing the livelihoods of the Rohingya refugees in Bangladesh with particular reference to the 2020 pandemic and discussing the growing tension between the refugees and the local Bangladeshis.
Elsevier,

Pandemic Risk, Response, and Resilience, COVID-19 Responses in Cities Around the World, 2022, Pages 3-12

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by providing an understanding of understand the inequalities between countries and shifting modality in risk governance. The case studies of COVID-19 pandemic impacts, governance, and consequences have been analyzed from various perspectives at the local, national, and regional levels.
Elsevier,

Neurobiology of Brain Disorders (Second Edition): Biological Basis of Neurological and Psychiatric Disorders, 2022, Pages 1009-1023

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by providing an overview of current knowledge of racial/ethnic inequities in health with a focus on the United States and the potential contribution of psychosocial stressors to account for them.

Pages